Details checkedClinical trial listing onlyCheckedregistry

Institut Pasteur REFINED AI speech-enhancement study

Also known as: REFINED, Evaluation of the denoising methods REFINED, Real-time AI-based speech enhancement methods for hearing aid improvement, NCT05985473

Institution-led study

Primary source

Sponsor / Institution

Institution-led study

Program Type

Software/Neurotech

Modality

Hearing Aid/Software

Stage

Interventional/NA

Status

Active

Target Gene

—

Route / Mode

Software-based speech enhancement during audiological testing

Confidence

82%

Status Confidence

Status needs checking

Evidence Strength

Needs more support

Last Reviewed

2026-06-09

Geography

France

Population

adult, sensorineural, speech-in-noise, hearing-aid-user, healthy-volunteer

Trial IDs

Mechanism

Recruiting study evaluating real-time AI-based speech-enhancement and denoising methods intended to improve speech-in-noise performance for auditory neuropathy spectrum disorders and broader hearing-aid use cases.

Indications

Hearing Loss Sensorineural Hearing Loss Hidden Hearing Loss

Notes

Normalized from a generic denoising-methods row into the active REFINED AI speech-enhancement study. No commercial software owner was verified; keep as institution-led research.

Evidence & Sources

1 structured sources

clinicaltrials

Supports: canonicalName, aliases, allCompanies, isIndustrySponsored, stage, status, route, indications...

IDs: NCT05985473

Open

Key Events

2024-03-06

REFINED study started

2024-03-15

ClinicalTrials.gov posted latest REFINED update reviewed in this pass

Clinical Trials (1)